Concepedia
Statistics
Publications
7
Citations
255
H-Index
Active since
2020
Affiliations
Sanofi (United States)(Current)
BioStrategies (United States)
Naimisha Movva is an author at Sanofi (United States).
Publications per year
2020–2023
Respiratory Syncytial Virus Is the Leading Cause of United States Infant Hospitalizations, 2009–2019: A Study of the National (Nationwide) Inpatient Sample
Mina Suh, Naimisha Movva, Xiaohui Jiang et al. · The Journal of Infectious Diseases · 2022 · 118 citations · Full text
Mortality Associated With Respiratory Syncytial Virus, Bronchiolitis, and Influenza Among Infants in the United States: A Birth Cohort Study From 1999 to 2018
Heidi Reichert, Mina Suh, Xiaohui Jiang et al. · The Journal of Infectious Diseases · 2022 · 30 citations · Full text
Respiratory Syncytial Virus Burden and Healthcare Utilization in United States Infants <1 Year of Age: Study of Nationally Representative Databases, 2011–2019
Mina Suh, Naimisha Movva, Xiaohui Jiang et al. · The Journal of Infectious Diseases · 2022 · 29 citations · Full text
Respiratory Syncytial Virus During the COVID-19 Pandemic Compared to Historic Levels: A Retrospective Cohort Study of a Health System
Naimisha Movva, Mina Suh, Heidi Reichert et al. · The Journal of Infectious Diseases · 2022 · 27 citations · Full text
Evaluation of claims‐based computable phenotypes to identify heart failure patients with preserved ejection fraction
Sarah S. Cohen, Véronique L. Roger, Susan A. Weston et al. · Pharmacology Research & Perspectives · 2020 · 24 citations · Full text
1–5 of 7